Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Srinivas Rao Biography and Net Worth

Insider of Atai Life Sciences

Srinivas Rao is the Chief Scientific Officer at atai Life Sciences AG. Dr. Rao has over 19 years of professional experience in the pharmaceutical and biotechnology industries. Prior to atai, Dr. Rao has held the titles of Chief Scientific, Medical, or Executive Officer at companies ranging from venture backed startups to vertically-integrated, publicly traded pharmaceutical companies.

Dr. Rao completed an internship in Internal Medicine at Yale-New Haven Hospital. He received his Ph.D. in neurobiology from Yale Graduate School and his M.D. from Yale School of Medicine. He holds both a Bachelor of Science and Master of Science degree in Electrical Engineering from Yale College and Yale Graduate School, respectively.

What is Srinivas Rao's net worth?: The estimated net worth of Srinivas Rao is at least $211,983.20 as of April 2nd, 2024. Dr. Rao owns 113,360 shares of Atai Life Sciences stock worth more than $211,983 as of April 25th. This net worth approximation does not reflect any other investments that Dr. Rao may own. Additionally, Dr. Rao receives an annual salary of $834,150.00 as Insider at Atai Life Sciences. Learn More about Srinivas Rao's net worth.
How old is Srinivas Rao?: Dr. Rao is currently 55 years old. There are 6 older executives and no younger executives at Atai Life Sciences. Learn More on Srinivas Rao's age.
What is Srinivas Rao's salary?: As the Insider of Atai Life Sciences, Dr. Rao earns $834,150.00 per year. The highest earning executive at Atai Life Sciences is Mr. Florian Brand, Co-founder & CEO, who commands a salary of $835,440.00 per year. Learn More on Srinivas Rao's salary.
How do I contact Srinivas Rao?: The corporate mailing address for Dr. Rao and other Atai Life Sciences executives is c/o Mindspace Krausenstra sse 9-10, Berlin, Berlin 10117. Atai Life Sciences can also be reached via phone at 49-89-2153-9035 and via email at [email protected]. Learn More on Srinivas Rao's contact information.
Has Srinivas Rao been buying or selling shares of Atai Life Sciences?: Over the course of the past ninety days, Srinivas Rao has sold $114,034.00 of Atai Life Sciences stock. Most recently, Srinivas Rao sold 61,640 shares of the business's stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $1.85, for a transaction totalling $114,034.00. Following the completion of the sale, the insider now directly owns 113,360 shares of the company's stock, valued at $209,716. Learn More on Srinivas Rao's trading history.
Who are Atai Life Sciences' active insiders?: Atai Life Sciences' insider roster includes Christian Angermayer (Director), Srinivas Rao (Insider), and Gregory Weaver (CFO). Learn More on Atai Life Sciences' active insiders.
Are insiders buying or selling shares of Atai Life Sciences?: During the last year, Atai Life Sciences insiders bought shares 2 times. They purchased a total of 60,000 shares worth more than $81,200.00. During the last year, insiders at the sold shares 2 times. They sold a total of 89,050 shares worth more than $164,742.50. The most recent insider tranaction occured on April, 2nd when CFO Anne Nagengast Johnson sold 27,410 shares worth more than $50,708.50. Insiders at Atai Life Sciences own 30.0% of the company. Learn More about insider trades at Atai Life Sciences.
Information on this page was last updated on 4/2/2024.

Srinivas Rao Insider Trading History at Atai Life Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/2/2024	Sell	61,640	$1.85	$114,034.00	113,360

Srinivas Rao Buying and Selling Activity at Atai Life Sciences

Atai Life Sciences Company Overview

ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; GRX-917, a deuterated etifoxine for anxiety disorders; VLS-01 a N,N-Dimethyltryptamine for treatment resistant depression (TRD); DMX-1002, an oral formulation of ibogaine, a cholinergic, glutamatergic and monoaminergic receptor modulator that is a naturally occurring psychedelic product isolated from a West African shrub for the treatment of opioid use disorders (OUD); and EMP-01, an oral formulation of an MDMA derivative being developed for the treatment of post-traumatic stress disorder. The company's other clinical programs comprise PCN-101, a subcutaneous formulation of R-ketamine, as a therapy for psychiatric indications initially focused on TRD; and KUR-101, a formulation of deuterated mitragynine for the treatment of OUD. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany with offices in New York and London.

Today's Range

Now: $1.87

$1.85

$1.95

50 Day Range

MA: $1.98

$1.63

$2.60

2 Week Range

Now: $1.87

$1.03

$2.85

Volume

842,714 shs

Average Volume

2,245,403 shs

Market Capitalization

$313.06 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Srinivas Rao Biography and Net Worth

What is Srinivas Rao's net worth?

How old is Srinivas Rao?

What is Srinivas Rao's salary?

How do I contact Srinivas Rao?

Has Srinivas Rao been buying or selling shares of Atai Life Sciences?

Who are Atai Life Sciences' active insiders?

Are insiders buying or selling shares of Atai Life Sciences?